BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23813602)

  • 1. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.
    El Kouni MH
    Comp Biochem Physiol B Biochem Mol Biol; 2017 Nov; 213():55-80. PubMed ID: 28735972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 5. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
    Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in development of new antischistosomal drugs in recent years].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Jun; 28(3):218-25. PubMed ID: 20806509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human schistosomiasis.
    Gryseels B; Polman K; Clerinx J; Kestens L
    Lancet; 2006 Sep; 368(9541):1106-18. PubMed ID: 16997665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
    Doenhoff MJ; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.